US 7557212
Tricyclic derivatives as LTD4 antagonists
granted A61PA61P1/04A61P11/00
Quick answer
US patent 7557212 (Tricyclic derivatives as LTD4 antagonists) held by Laboratories Almirall, S.A. expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Laboratories Almirall, S.A.
- Grant date
- Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P1/04, A61P11/00, A61P11/02, A61P11/06